Corcept Therapeutics Incorporated (0I3Q.L) has a MoatMap StockRank of 9/100 based on Quality (56/100), Value (22/100), and Momentum (16/100) factor scores. The current signal is STRONG SELL. Corcept Therapeutics Inc., a US healthcare (pharma) company, does not directly align with the identified macro themes of energy, trade, or critical materials. Its business performance is driven by drug development and market penetration, not by the macro inflections.